Pharmaceuticals, Biotechnology and Life Sciences
Several leaders of some of the largest pharmaceutical companies have met on Tuesday with the newly elected US president, Donald Trump to discuss industry related topics, agreeing that the talks were positive.
Akers Biosciences, a developer of rapid health information technologies, expects the total revenue for the 2016 year to be about…
U.S. President Donald Trump in a meeting on Tuesday with pharmaceutical executives called on them to manufacture more of their drugs in the United States and cut prices, while vowing to speed approval of new medicines and ease regulation.
The newly appointed president of the United States of America, Donald Trump said that he wants pharmaceutical companies to manufacture their products in America, during the meeting he held with leaders of some of the major drugmakers.
U.S. President Donald Trump, who has accused drugmakers of “getting away with murder” on prices, will meet executives from the pharmaceutical industry at the White House on Tuesday.
Driven by new products, including Trulicity, Cyramza, Jardiance and Taltz, Lilly’s volume-driven significant growth in 2016.
GenSight Biologics, a biopharma company that discovers and develops innovative gene therapies for neurodegenerative retinal diseases and diseases of the central nervous system, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to the Company’s product candidate GS030 for the treatment of retinitis pigmentosa.
Teva’s two asthma treatments for patients older than 12 has been approved by the US Food and Drug Administration (FDA).
Israel’s largest drugmaker, Teva, has came up short yet again against a US courts regarding patent infringement cases.
Aralez Pharmaceuticals will press charges against Teva in the USA for infringing four patents.